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Satellite cells (SCs) are skeletal muscle stem cells residing quiescent around healthy muscle fibres. In
response to injury or disease SCs activate, proliferate and eventually differentiate and fuse to one another to
form new muscle fibres, or to existing damaged fibres to repair them. The sulfated polysaccharide heparan
sulfate (HS) is a highly variable biomolecule known to play key roles in the regulation of cell fate decisions,
though the changes that muscle HS undergoes during SC differentiation are unknown. Here we show that the
sulfation levels of HS increase during SC differentiation; more specifically, we observe an increase in 6-O and
2-O-sulfation in N-acetylated disaccharides. Interestingly, a specific increase in 6-O sulfation is also observed
in the heparanome of ageing muscle, which we show leads to promotion of FGF2 signalling and satellite cell
proliferation, suggesting a role for the heparanome dynamics in age-associated loss of quiescence. Addition
of HS mimetics to differentiating SC cultures results in differential effects: an oversulfated HS mimetic
increases differentiation and inhibits FGF2 signalling, a known major promoter of SC proliferation and inhibitor
of differentiation. In contrast, FGF2 signalling is promoted by an N-acetylated HS mimetic, which inhibits
differentiation and promotes SC expansion. We conclude that the heparanome of SCs is dynamically
regulated during muscle differentiation and ageing, and that such changes might account for some of the
phenotypes and signalling events that are associated with these processes.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Introduction
Heparan sulfate proteoglycans (HSPGs) are com-
plex biomolecules composed by a core protein to
which polysaccharide chains, called heparan sulfate
(HS) glycosaminoglycans (GAGs), are covalently
bound. HSPGs exert their function through several
mechanisms, a major one being the modulation of the
bioavailability and activity of heparin-binding growth
factors, which depend largely on the structure of the
HS GAGs attached to HSPG core proteins [1–3].
HS is a linear polysaccharide composed by a
variable number (10–200) of repeating disaccharide
units of N-acetyl- or N-sulfo-D-glucosamine (GlcNAc)
linked to an uronic acid, which is either D-glucuronic
acid (GlcA) or its epimer L-iduronic acid (IdoA). HS
disaccharides can be sulfated in various positions by
specific enzymes. The most common positions forAuthor. Published by Elsevier B.V. T
rg/licenses/by/4.0/).
: R.S. Ghadiali, et al., Dynamic changes in h
GF2 signalling, Matrix Biol (2016), http://dxHS sulfation are: the 6-O and N- positions of the
glucosamine residue and the 2-O position of the
uronic acid residue. Additionally, a more rare sulfation
occurs on the 3-O position of the glucosamine residue
[4]. Heparin is a type of HS that: (i) contains mostly
L-iduronic acid instead of D-glucuronic acid in its
backbone, (ii) is more highly sulfated (due to a
prevalence of N-sulfation as opposed to the preva-
lence of N-acetylation observed in HS) and (iii) on
average is slightly smaller than HS. Although it is
typically recognised that HS is produced in virtually all
tissues while heparin is produced only bymast cells, it
has been shown that HS with features close to those
of heparin are also produced by cell types other than
mast cells, such as endothelial cells and glia [5,6].
Moreover, HS with features typical of heparin has
been found in various tissues, such as lung and liver
[7,8].his is an open access article under the CC BY license
Matrix Biol. (2016) xx, xxx–xxx
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2 Heparan Sulfate in MyogenesisHS plays key roles in multiple biological processes
such as cell growth, development, cell signalling and
coagulation [1,9]. The different functions played by
HS depend mostly on its structural composition,
which arise from the different levels and combina-
tions of sulfation harboured by the disaccharide units
[1]. For example, a prototype of HS-protein interac-
tion is the formation of the ternary signalling complex
that includes fibroblast growth factor (FGF), FGF
receptor and HS. It has been shown that in the
formation of this ternary signalling complex specific
disaccharides containing specific degrees and pat-
terns of sulfation are preferred over others [10],
further supporting the idea that HS has evolved as a
highly diverse regulator of cell signalling with binding
specificity and selectivity.
Muscle satellite cells (SCs) are undifferentiated,
quiescent muscle stem cells residing in a specialised
anatomical niche between the muscle fibre plasma
membrane and the surrounding basal lamina [11]. In
response to injury SCs become activated, proliferate
as myoblasts, differentiate and fuse to pre-existing or
new muscle fibres thus effectively regenerating the
lost muscle fibres [12].
Several GAGs are present in the SC niche,
including HS, chondroitin sulfate (CS) and dermatan
sulfate (DS) [13,14]. Interestingly, total sulfated GAG
amounts increase in the C2.7 myoblast cell line when
myoblasts are differentiated to myotubes [15] indicat-
ingGAGsas important regulators ofmyogenesis– the
process of muscle formation. Indeed, expression of
various HSPGs is regulated during muscle regener-
ation and functionally involved in several signalling
pathways such as FGF, HGF, Notch1 and Wnt7a
[16–25]. Genetic ablation or modulation of HSPGs
expressed in SCs, such as syndecan-3 and
syndecan-4, dramatically affect muscle regeneration
in response to injury and SC homeostasis [18,20].
Moreover, genetic ablation of the two extracellular
sulfatases that remove 6-O-sulfation from HS, Sulf1
and Sulf2, also leads to impaired SC function [26].
While regulation and function of HSPG core proteins
during myogenesis has been studied [27], regulation
of HS composition during myogenesis remains a
largely unexplored area. Through phage display
technology, it has been shown that different HS
epitopes exist in skeletal muscle, and their abundance
changes in developing muscle in vitro and in vivo
[13,14]. Moreover, it is known that the amounts of HS
and CS increase during ischemia-induced muscle
injury and that the levels and patterns of HS and CS
sulfation change [28]. These results suggest a
potential role for specific structural moieties of the
HS chains in regulating skeletal muscle regeneration.
However, it is still largely unknown if the structure of
SC HS changes during these processes and how
different HS structures affect SC function.
During ageing skeletal muscle loses mass and
strength, a process called sarcopenia, and regen-Please cite this article as: R.S. Ghadiali, et al., Dynamic changes in h
myoblast cell fate and FGF2 signalling, Matrix Biol (2016), http://dx.erative capacity. This is due to both intrinsic SC
impairment and changes in molecular signalling that
occur in the SC niche [29–32]. Interestingly, HS
regulates several signalling events that are reportedly
altered in the aged SC niche, such as FGF2 signalling
[31,33]. Moreover, age-related changes in HS have
been reported in some human tissues including aorta
and cardiac muscle [34,35]. Thus, it is plausible that
age-associated changes in themuscle heparanome –
the complex mixture of various HS structures present
in a tissue – underlie some of the molecular
mechanisms that impair SChomeostasis and function
in aged muscle.
In this study we investigate whether HS sulfation
levels and patterns are dynamically regulated during
muscle differentiation and ageing and these chang-
es affect satellite cell proliferation and signalling.
Moreover, we exploit a library of HS mimetics to
systematically test the role of differential HS sulfation
in SC differentiation and FGF2 signalling.Results and discussion
The level of sulfation of the muscle stem cell
heparanome increases with differentiation
During myogenic dif ferent iat ion primary
SC-derived myoblasts undergo numerous morpho-
logical and molecular changes. Proteins typical of
mature muscle cells, such as muscle myosins, are
absent in proliferating cells but expressed in
differentiating cells. In contrast, cell cycle markers
such as 5-Bromo-2′-deoxyuridine (BrdU) incorpora-
tion are abundant in cultures of proliferating cells
but nearly absent in cultures of differentiating cells
(Fig. 1A). Moreover, differentiated cells fuse to one
another and generate multinucleated cells called
myotubes, which are the ex vivo equivalent of young,
immature, muscle fibres (Fig. 1A). HS controls many
signalling pathways involved in differentiation of
muscle progenitors and thus, we hypothesised that
the SC heparanome may change during differenti-
ation, and potentially be a factor controlling the
balance between proliferation and differentiation. To
test this hypothesis we extracted and profiled HS
from proliferating and differentiating primary
SC-derived myoblasts (Fig. 1B) and quantified their
abundance with reference to a set of authentic
disaccharide standards (Table 1). While in cultures
of proliferating myoblasts there was an even
distribution between non-sulfated disaccharides
and sulfated disaccharides, in differentiated cultures
this balance was markedly altered, with an increase
in sulfated disaccharides at the expense of
non-sulfated disaccharides (Fig. 1C).
When the relative abundance of mono-sulfated,
di-sulfated and tri-sulfated disaccharides waseparan sulfate during muscle differentiation and ageing regulate
doi.org/10.1016/j.matbio.2016.07.007
Fig. 1. SC HS structure is dynamically regulated during myogenic differentiation. A) Representative images of
proliferating and differentiating primary satellite cell-derived myoblasts where proliferation is detected via BrdU
incorporation and immunostaining (red), while differentiation is identified via expression of myosin heavy chain (MyHC,
green). B) Schematic showing the main steps in the process of HS extraction, digestion to release individual disaccharide
units, labelling of the reducing end of the disaccharides, purification and profiling via HPLC from proliferating and
differentiated cells. C–E) HS is more sulfated in differentiated myoblast cultures compared to proliferating myoblast
cultures. In (C) the percentage of non-sulfated (Δ-UA-GlcNAc, unsulfated, black bars) and sulfated (sum of all sulfated,
grey bars) disaccharides is plotted, based on the data from panel D. In (D) the percentage of non-sulfated Δ-UA-GlcNAc
disaccharide (no-S) and the sum of the percentages of all mono-sulfated (mono-S), di-sulfated (di-S) and tri-sulfated (tri-S)
disaccharides are plotted based on data from panel (E). In (E) each disaccharide entity is represented as percentage of the
total amount of disaccharides identified as in (B) against a set of authentic disaccharide standards (Table 1) and plotted as
averages of four independent experiments ± S.E.M. * = p b 0.05. (For interpretation of the references to colour in this
figure legend, the reader is referred to the web version of this article.)
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Table 1. Disaccharide reference standards for SAX-HPLC
characterisation of extracted HS.
Standard ID Standard structure Elution time
I-S Δ-UA-GlcNAc 12.78
II-S Δ-UA-GlcNS 21.26
III-S Δ-UA-GlcNAc(6S) 18.59
IV-S Δ-UA(2S)-GlcNAc 37.51
I-A Δ-UA-GlcNS(6S) 31.14
II-A Δ-UA(2S)-GlcNS 27.66
III-A Δ-UA(2S)-GlcNAc(6S) 46.08
IV-A Δ-UA(2S)-GlcNS(6S) 31.14
4 Heparan Sulfate in Myogenesisquantified, we observed a statistically significant
increase in mono-sulfated disaccharides, which was
accompanied by a marked decrease in non-sulfated
disaccharides though the latter did not reach statistical
significance (Fig. 1D).
Thus, during SC differentiation, the overall sulfation
levels of HS increase, a phenomenon that is reminis-
cent of the increase in HS sulfation previously reported
to occur during differentiation of embryonic stem (ES)
cells into embryoid bodies [36] and during ES cell
neural differentiation [37]. Moreover, it has been shown
that genetic targeting of NDST1 and NDST2, the two
enzymes that promote de-acetylation and sulfation of
N-acetyl-glucosamine moieties in HS [38], inhibits ES
cell adipogenic and neural differentiation [39]. Similarly,
a lack of HS inhibits neural and haematopoietic
differentiation of ES cells [40,41]. In contrast, functional
reduction of HS sulfation promotes de novo ES cell
derivation [42]. Thus, there is increasing evidence that
the sulfation level of HS in stem cell niches is a major
factor contributing to stem cell fate. In this context our
findings reveal that SCsare anadditional stemcell type
whose differentiation is associated with increased HS
sulfation.
Most notably the increase in HS sulfation that we
observed during primary SC-derived myoblast differ-
entiation was specifically due to an increase in both
Δ-UA-GlcNAc(6S) and Δ-UA(2S)-GlcNAc (Fig. 1E).
Although the total amount of 6-O-sulfation does not
appear to significantly change in differentiating versus
proliferating SCs (data not shown), the observed
increase in one of the 6-O-sulfated disaccharides is
interesting since we had previously shown that the
extracellular sulfatases, Sulf1 and Sulf2, which
remove 6-O-sulfation from HS, are dramatically
downregulated during SC activation and differentia-
tion in vivo [22]. This downregulation of Sulfs during
SC activation is consistent with our finding here that
the levels of Δ-UA-GlcNAc(6S) increase during SC
differentiation in vitro (Fig. 1E) although it apparently
contrasts with findings by Langsdorf et al. that mice
lacking both Sulf1 and Sulf2 show delayed SC
differentiation in vivo upon muscle injury [43]. How-
ever, these data may not be discordant since
compensation mechanisms are likely acting in the
more extreme scenario of Sulf1/2−/− mice and thisPlease cite this article as: R.S. Ghadiali, et al., Dynamic changes in h
myoblast cell fate and FGF2 signalling, Matrix Biol (2016), http://dx.should be taken into account. Indeed, inSulf1/2−/− SC
cultures two of the three 6-O-sulfated disaccharides
analysed were decreased and only one was in-
creased [43], further supporting the widespread idea
that it is not possible to directly predict changes in HS
structure based simply on changes in the expression
levels of the biosynthetic enzymes.
The muscle heparanome is altered with ageing
The number of quiescent SCs and their regener-
ative potential are reduced with ageing [31,33] and
accompanied by alterations in MAPK signalling
[29,30], which is strongly affected by the extracellular
heparanome [44,45]. Furthermore, previous studies
have shown age-related changes in HS structures in
other tissues [34,35]. Thus, we reasoned that
changes in the muscle heparanome might also be
an important underlying factor in the signalling
alterations observed in aged SCs. To investigate
ageing-associated changes in the muscle hepara-
nome, we profiled HS from 3-month-, 1-year- and
2-year-old mouse muscles. Although the relative
abundance of individual disaccharides did not
change significantly with age (Fig. 2A), we observed
an overall increase in 6-O-sulfation in the quadriceps
of older mice (1-year- and 2-year-old) compared to
young mice (3-month-old), while 2-O-sulfation only
showed a trend towards a decrease that did not
reach statistical significance (Fig. 2B). Importantly,
the changes observed in 6-O-sulfation were already
detectable in 1-year old mice. Since sarcopenia and
muscle fibrosis are not present at 12 months of age
[46], our data indicate that important changes at the
molecular level are already occurring in the muscle
extracellular environment before any macroscopic
changes at the tissue or functional level are
detected. Moreover, we speculate that the increase
in 6-O-sulfation that we observe in aged muscle
could have important consequences on the level of
activation of resident SCs. It has been reported that
FGF2 signalling is increased in aged muscle and
leads to SC hyper-activation and consequent ex-
haustion [31,33]. Since 6-O-sulfation promotes
FGF2 signalling [47,48], it is reasonable to speculate
that the increase in FGF2 signalling observed in
aged SCs is, at least in part, due to the increased
6-O-sulfation that we observed in the muscle
heparanome. To test this hypothesis we used a
BaF3 cell assay which takes advantage of the
absence of HS in BaF3 lymphoid cell cultures
where an exogenous source of HS is required in
order to promote FGF signalling [10]. We employed
a BaF3 cell line stably transfected to express the
FGF receptor 1, which is the main FGF receptor
expressed by myoblasts [49] and HS extracted from
3 month-old and 2 year-old mice to study the role of
ageing on HS-mediated regulation of FGF2 mito-
genic activity as a measure of FGF2 signalling.eparan sulfate during muscle differentiation and ageing regulate
doi.org/10.1016/j.matbio.2016.07.007
Fig. 2. Muscle HS shows an age-associated increase in 6-O-sulfation which promotes FGF2 signalling and myoblast
proliferation. Quadriceps muscles from 3 month-old (black bars), 1 year-old (light grey bars) and 2 year-old (dark grey
bars) were treated and analysed as in Fig. 1A to profile HS composition. A) No significant differences in the relative
abundance of individual disaccharide units were observed. B) Analysis of the abundance of specific sulfate groups:
6-O-sulfation (6S), N-sulfation (NS) and 2-O-sulfation (2S) reveals a significant increase is 6-O-sulfation in the muscle of
1 year-old and 2 year-old mice compared to the muscle of 3 month-old mice. Muscles from at least 4 animals (n = 5 in the
2 years age group, n = 4 in the 3 months and 1 year age groups) were analysed and plotted as averages ± S.E.M.
C) BaF3 cell assay where the mitogenic activity of FGF2 on BaF3 cells was measured in response of FGF2 alone or in the
presence of FGF2 and HS extracted from the muscles of either 3 month-old or 2 year-old mice. Data from 3 independent
experiments with 4 technical replicates were analysed and plotted as averages ± S.E.M. D) GFP (pClover) and siRNA
simultaneously to the three HS6STs or control scrambled siRNA were transfected into C2C12 myoblasts and 24 h later
10 μM BrdU was added to the culture medium 2 h prior to fixation and immunostaining to detect GFP and BrdU.
Simultaneous knockdown of all three HS6STs produces a significant decrease in C2C12 myoblast proliferation. * =
p b 0.05, ** = p b 0.01.
5Heparan Sulfate in MyogenesisWhen cells were treated with HS extracted from
3 month-old mice baseline FGF2 signalling, as
measured by the mitogenic activity of FGF2 on
BaF3 cells, was not enhanced at 0.1 and 1 μg/ml
doses, and was partially reduced at the 10 μg/ml
dose (Fig. 2C). In contrast, when cells were treated
with HS extracted from 2 year-old mice, the
mitogenic activity of FGF2 was increased signifi-
cantly at the highest dose administered (10 μg/ml
dose) compared to cells treated with FGF2 alone
(Fig. 2C). These data strongly support a key role for
aged muscle HS in the loss of quiescent SCs
observed in mouse muscle with ageing and,
together with the observation that changes in HS
structure are already present in 1 year-old mice,Please cite this article as: R.S. Ghadiali, et al., Dynamic changes in h
myoblast cell fate and FGF2 signalling, Matrix Biol (2016), http://dxsuggest that an increase in FGF2 signalling occurs
early in the ageing process and leads over time to
exhaustion of SCs, and subsequent accumulation
of muscle fibrosis and sarcopenia [50].
We have shown that 6-O sulfation is increased in
aged muscle (Fig. 2B) and that this increase in
6-O-sulfation is associated with increased FGF2
mitogenic activity in a BaF3 cell assay (Fig. 2C). To
further test the role of 6-O sulfation in myoblast
proliferation we used RNAi technology to
knock-down the three murine 6-O-sulfotransferases
(HS6ST1, HS6ST2 and HS6ST3) in myoblasts
(Supplementary Fig. S1) and study proliferation in
response to reduction in 6-O-sulfation. When all
three HS6STs were knocked-down simultaneouslyeparan sulfate during muscle differentiation and ageing regulate
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6 Heparan Sulfate in Myogenesis(Fig. 2D), myoblast proliferation was significantly
decreased by approximately 50%, further supporting
the hypothesis that 6-O sulfation promotes myoblast
proliferation and that the observed age-associated
increase in 6-O sulfation might be responsible for
satellite cell hyper-activation and consequent ex-
haustion via FGF2.
Exogenous HS mimetics differentially regulate
SC fate partly via regulation of FGF2 signalling
To model in a systematic and controlled way on
how changes in the composition of the SC nicheFig. 3. HS mimetics differentially affect myoblast differentia
disaccharide unit in heparin containing iduronic acid and N-Ace
sulfation indicated in red as R1 (2-O-sulfation), R2 (6-O-sulfati
SC-derived myoblasts cultured for 2 days and then induced to
both mono- and multi-nucleated are identified via immunosta
identified via staining with DAPI (blue). Scale bar = 200 μm is
(B) the differentiation index was calculated as the percentage
over the total number of nuclei (DAPI+). The average of ten im
experiments ± S.E.M. is calculated and plotted. D) For each
measured and the average of ten images across two technic
plotted. Asterisks are p-values for each condition compared to
signs are p-values for each condition compared to heparin-trea
the references to colour in this figure legend, the reader is refe
Please cite this article as: R.S. Ghadiali, et al., Dynamic changes in h
myoblast cell fate and FGF2 signalling, Matrix Biol (2016), http://dx.heparanome might influence myogenic differentia-
tion, we produced a library of diversely sulfated HS
mimetics by selective chemical modification of
heparin [51]. Heparin is a type of HS containing a
high degree of sulfation in all three key positions (2S,
6S, NS), and can be exploited as a starting material
to generate HS mimetics containing increased or
decreased levels of sulfation in specific positions
(Fig. 3A and Table 2). Through this process we
obtained a library of HS mimetics containing lower
levels of sulfation than native heparin, distributed in
all possible combinations of the three types of HS
sulfation, and therefore mimicking the variant typestion and cell numbers. A) Schematic of the most abundant
tyl-glucosamine (IdoA-GlcNAc) with the three main sites of
on), R3 (N-sulfation). B) Representative images of primary
differentiate for an additional 3 days. Differentiated cells,
ining for myosin heavy chain (MyHC, green). Nuclei are
equal across all images. C) For each condition shown in
of nuclei in MyHC+ cells (both mono- and multi-nucleated)
ages across two technical replicates for three independent
condition shown in (B) the total number of nuclei was
al replicates for three independent experiments ± S.E.M.
non-treated (NT) cells. ** = p b 0.01; * = p b 0.05. Hash
ted cells. ## = p b 0.01; # = p b 0.05. (For interpretation of
rred to the web version of this article.)
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Table 2. List of HS mimetics obtained by selective chemical modification of heparin.
Modified heparin HS mimetic Figure annotation R1 R2 R3 Additional modification
Heparin Heparin SO3
− SO3
− SO3
−
Oversulfated heparin HS mim 1 SO3
− SO3
− SO3
− SO3
− at C3 of GlcN and C3 of IdoUA
N-acetylated heparin HS mim 2 SO3
− SO3
− COCH3
2 de-sulfated-N-sulfated heparin HS mim 3 H SO3
− SO3
−
6 de-sulfated-N-sulfated heparin HS mim 4 SO3
− H SO3
−
2 de-sulfated-N-acetylated heparin HS mim 5 H SO3
− COCH3
6 de-sulfated-N-acetylated heparin HS mim 6 SO3
− H COCH3
2,6 de-sulfated-N-sulfated heparin HS mim 7 H H SO3
−
2,6 de-sulfated-N-acetylated heparin HS mim 8 H H COCH3
7Heparan Sulfate in Myogenesisof HS normally found in tissues: completely
de-sulfated HS (HS mimetic 8), HS with sulfation
in only one position (HS mimetic 5, HS mimetic 6
and HS mimetic 7), HS with sulfation in two
positions (HS mimetic 2, HS mimetic 3 and HS
mimetic 4). Additionally, we produced HS with
sulfation in more than the three canonical positions
(oversulfated heparin, HS mimetic 1, in which
additional 3-O-sulfate groups are present on glu-
cosamine and uronic acid rings) (Table 2). We then
asked how altering the SC extracellular hepara-
nome via addition of specific exogenous HS
mimetics affects myogenic differentiation.
SC-derived primarymyoblasts were treatedwith the
HS mimetics generated as above concomitant with
induction of myogenic differentiation (see Methods
section for details). We found that the effect of
different HS mimetics on myoblast differentiation
was structure-specific and concentration-dependent
with the lowest doses tested often leading to
non-significant differences compared to absence of
treatment (Fig. 3B–C). However, at the higher
concentrations tested (100 and 1000 ng/ml) almost
all the HS mimetics, except oversulfated heparin
(HS mimetic 1), produced a marked reduction in
differentiation (Fig. 3B–C). This general reduction
in differentiation was accompanied by an overall
increase in cell numbers (Fig. 3B, D) with the HS
mimetics that decreased differentiation the most (HS
mimetic 2, HS mimetic 3 and HS mimetic 4) showing
also the greatest effects on increasing cell numbers
(Fig. 3B–D). In myoblasts, differentiation and prolifer-
ation are mutually exclusive and thus, these observa-
tions suggest that addition of HS in the presence of
low serum increases the activity of pro-proliferative
and/or anti-differentiative signals, which in turn delays
differentiation and promotes cell expansion. The
exception to this general trend was provided by
oversulfated heparin (HS mimetic 1), which did not
reduce differentiation even at high concentration
(Fig. 3B–C), but dramatically reduced cell num-
bers (Fig. 3B, D). It was unlikely that this reduction
in cell numbers was due to cell detachment or cell
death, since no detached or dead cells were
observed. Instead it was likely due to induction of
cell cycle arrest. The interesting finding that
oversulfated heparin (HS mimetic 1) producesPlease cite this article as: R.S. Ghadiali, et al., Dynamic changes in h
myoblast cell fate and FGF2 signalling, Matrix Biol (2016), http://dxcell cycle arrest is consistent with the observation
that sulfation levels of endogenous HS increase
when SC-derived myoblasts exit the cell cycle to
differentiate (Fig. 1).
We then studied whether the HS mimetics affected
myoblast fusion by scoring the percentage of differen-
tiated (expressing myosin heavy chain, MyHC) cells
found in multinucleated myotubes. Not surprisingly
myoblast fusion was affected by the presence of HS
mimetics in a similar way to myoblast differentiation
(Supplementary Fig. S2), suggesting that the hepar-
anome is not directly involved in the signalling
pathways that control myoblast fusion.
We have shown that muscle ageing is associated
with an increase in 6-O-sulfation (Fig. 2) and it is
well established that aged SCs are impaired
[29,30,32,52,53]. Thus, it is intriguing to ask whether
any of the HS mimetics tested could be considered a
proxy for agedmuscle HS. An increase in 6-O sulfation
might be mimicked by 2-de-sulfated-N-acetylated
heparin (HS mimetic 5), which contains a greater
proportion of 6-O-sulfation as a result of selective
de-sulfation of the 2-O and N positions. This HS
mimetic indeed inhibits myogenesis by inhibiting
myoblast differentiation without promoting proliferation
(Fig. 2B–D) further supporting a key role for
HS-mediated signalling in age-associated SC
impairment.
FGF2 signalling via Erk1/2 and mitogenic activity
are differentially affected by different HS
structures in myoblasts
FGF2 strongly promotes myoblast expansion by
inhibiting differentiation and requires HS to signal
[16,54–56]. Moreover, FGF2 signalling is sensitive to
the degree and pattern of HS sulfation [10]. Since
we have shown that: (i) myoblast differentiation is
associated with increased sulfation levels (Fig. 1)
and (ii) oversulfated heparin (HS mimetic 1) is the
only HS mimetic that does not inhibit differentiation
but inhibits cell expansion, we hypothesised that
oversulfated heparin might inhibit FGF2 signalling in
myoblasts by increasing the total amount of sulfated
HS in the extracellular environment. To test this
hypothesis, we treated myoblasts with FGF2 or
oversulfated heparin (HS mimetic 1) or aeparan sulfate during muscle differentiation and ageing regulate
.doi.org/10.1016/j.matbio.2016.07.007
8 Heparan Sulfate in Myogenesiscombination of the two after a period of serum
starvation and quantified the cellular response by
measuring Erk1/2 phosphorylation levels by West-
ern blotting. As expected, FGF2 addition produces
an increase in the levels of phospho-Erk1/2 as
measured 15 and 30 min after stimulation (Fig. 4A–
B). In contrast, the addition of HS mimetic 1
together with FGF2 does not produce an increase
in Erk1/2 phosphorylation, supporting the hypoth-
esis that HS mimetic 1 blocks FGF2 signalling (Fig.
4A–B). Moreover, the addition of HSmimetic 1 alone
produces a dramatic decrease in phospho-Erk1/2 after
15 and 30 min compared to the zero time point,
suggesting that the oversulfated HS mimetic 1 inhibitsFig. 4. FGF2 signalling via Erk1/2 and mitogenic activity
myoblasts were serum-starved for 6 h (lane 1) then stimulated
alone (lanes 4, 5) or FGF2 + HS mimetic 1 (1 μg/ml) together (
the stimulus cells were immediately lysed and analysed via W
and total Erk1/2. One representative of three independent ex
band intensity normalised to total Erk1/2 intensity. Moreover,
serum starvation) and the averages of three independent exp
alone at 15 and 30 minutes” which were averaged across
serum-starved for 6 h (lane 1) then stimulated with either 2 nM
(lanes 5, 6, 7) or FGF2 + HS mimetic 2 (lanes 8, 9, 10) for the
were immediately lysed and analysed via Western blotting to
One representative of three independent experiments is sho
normalised to total Erk1/2 band intensity, moreover all time
starvation) and the averages of three independent experiments
15 and 30 min” which were averaged across 6 independe
expanded for two days in growth medium then serum-starved o
either vehicle (NT), FGF2, FGF2 + HSmimetic 1 or FGF2 + HS
across three biological replicates were scored. Scale bars are
Please cite this article as: R.S. Ghadiali, et al., Dynamic changes in h
myoblast cell fate and FGF2 signalling, Matrix Biol (2016), http://dx.Erk1/2 signalling also in response to endogenous
paracrine signals (Fig. 4A–B).
In contrast to oversulfated heparin, the HS mimetic
N-acetylated heparin (HS mimetic 2) produced the
strongest opposing effect on myoblasts: it increased
cell numbers and dramatically reduced differentiation
(Fig. 3B–D). To test whether the anti-differentiative
and/or pro-proliferative effect of HS mimetic 2 on
differentiatingmyoblasts was alsomediated by FGF2,
we treated myoblasts with FGF2 in the presence or
absence of HS mimetic 2, after a period of serum
starvation and quantified the levels of Erk1/2 phos-
phorylation. We observed that myoblast response to
FGF2 was only modestly enhanced by the presenceare differentially regulated by HS mimetics. A) C2C12
with either 2 nM FGF2 alone (lanes 2, 3) or HS mimetic 1
lanes 6, 7) for the indicated amounts of time. At the end of
estern blotting to detect phosphorylated Erk1/2 (P-Erk1/2)
periments is shown. B) Quantification of phospho-Erk1/2
all time points were then normalised to time zero (end of
eriments plotted ± S.E.M., except for the condition “FGF2
6 independent experiments. C) C2C12 myoblasts were
FGF2 alone (lanes 2, 3, 4) or HS mimetic 2 (1 μg/ml) alone
indicated amounts of time. At the end of the stimulus cells
detect phosphorylated Erk1/2 (P-Erk1/2) and total Erk1/2.
wn. D) Quantification of phospho-Erk1/2 band intensity
points were then normalised to time zero (end of serum
plotted ± S.E.M., except for the condition “FGF2 alone at
nt experiments. E) Primary SC-derived myoblasts were
vernight to induce cell cycle exit followed by treatment with
mimetic 2. F) Quantification of (E) where ten random fields
=100 μm, * = p b 0.05.
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Fig. 5. Varied HS structures differentially affect satellite cell self-renewal ex vivo. A) Representative images of
SC-derived myoblasts cultured for 2 days and then induced to differentiate for an additional 3 days. Reserve cells are
identified via immunostaining for Pax7 (green). Nuclei are identified via staining with DAPI (blue). B) For each condition
shown in (A) the percentage of Pax7+ nuclei over the total number of nuclei was calculated and plotted as the average of
ten images across two technical replicates, each for three independent experiments ± S.E.M. ** = p b 0.01. C) Schematic
summary of the effect produced by HS mimetics on primary SC-derived myoblasts induced to differentiate.
Keys: P = proliferation, D = differentiation, S–R = self-renewal. (For interpretation of the references to colour in
this figure legend, the reader is referred to the web version of this article.)
9Heparan Sulfate in Myogenesisof HS mimetic 2, but, importantly, it was prolonged
over time: at 60 min of FGF2 stimulation the levels of
phospho-Erk1/2 were higher in the presence of HS
mimetic 2 compared to its absence (Fig. 4C–D). This
observation that HS mimetic 2 potentiates FGF2
signalling further supports the hypothesis that the
mechanism of action of HS mimetics on primary
myoblasts involves, at least in part, regulation of FGF2
signalling via Erk1/2.
To further explore the role of specific HS structures
on FGF2 signalling in myoblasts, we serum-starved
proliferating primary SC-derived myoblasts over-
night to induce cell cycle exit and then added
FGF2, either alone or in combination with HS
mimetics 1 and 2, to study their role in regulating
FGF2-induced re-entry into the cell cycle. As
expected, the number of cells re-entering the cell
cycle upon FGF2 stimulation was decreased in the
presence of HS mimetic 1 (Fig. 4E–F), which we had
previously shown to reduce FGF2 signalling
(Fig. 4A–B), and increased in the presence of HS
mimetic 2 (Fig. 4E–F), which we had shown increases
FGF2 signalling (Fig. 4C–D), compared to cellsPlease cite this article as: R.S. Ghadiali, et al., Dynamic changes in h
myoblast cell fate and FGF2 signalling, Matrix Biol (2016), http://dxtreated with FGF2 alone (Fig. 4E–F). Taken together
these data strongly support a role for specific HS
structures in regulating myoblast proliferation via
regulation of FGF2 signalling.
Different HS structures differentially regulate SC
self-renewal
Lastly, we tested whether different HS mimetics
affected SC self-renewal. In the muscle tissue, the
steady state number of undifferentiated progenitors
is determined by the equilibrium between the
number of cells that become activated and proceed
through the myogenic lineage and the number of
cells that return quiescent upon activation, a process
called self-renewal [12]. In primary SC-derived
myoblast cell culture models the process of SC
self-renewal is recapitulated when, during differen-
tiation, a population of cells exits the cell cycle but
instead of differentiating enters a quiescent state
similar to that of quiescent SCs in the intact muscle.
These self-renewing cells in culture are called reserve
cells and express the transcription factor Paired Box 7eparan sulfate during muscle differentiation and ageing regulate
.doi.org/10.1016/j.matbio.2016.07.007
10 Heparan Sulfate in Myogenesis(Pax7) [57]. To test whether changes in the
extracellular heparanome affected SC self-renewal,
we quantified the numbers of Pax7+ cells in
SC-derived myoblast cultures that had been induced
to differentiate and treated with the highest concentra-
tion (1000 ng/ml) of HS mimetics previously tested for
differentiationandcell expansion (Fig. 5A–B).Although
at this concentration all the HSmimetics tested, except
oversulfated heparin, produced a decrease in SC
differentiation, the effect on SC self-renewal was
variable. For example, HS mimetic 6 and HS mimetic
7 produced comparable effects on differentiation and
cell expansion but completely opposite effects on SC
self-renewal, with HS mimetic 6 inhibiting self-renewal
and HS mimetic 7 promoting self-renewal (Fig. 5C).
These observations strongly support the view that HS
regulates satellite cell fate in a complex manner that
cannot be simplified to a dichotomy between HS
structures that promote or inhibit differentiation. This is
typical of HS functions, since HS is a highly complex
biomolecule involved in the simultaneous regulation of
several signalling pathways.
Overall, in this study we show that a correlation
between structure and function of HS in myogenesis
exists as demonstrated by: (i) significant changes in
endogenous HS during differentiation and ageing; (ii)
matching differential effects of different extracted HS
or semi-synthetic HS mimetics on satellite cell fate
decisions and on regulating signalling pathways
relevant to SC fate; this was exemplified by FGF2
signalling, though effects on other pathways cannot
be excluded by our data. Although more investigation
is needed to further clarify the role of the heparanome
in myogenesis, in health, ageing and disease, our
data clearly indicate the heparanome as an important
dynamic and regulatory component for SC regulation.Experimental procedures
Mice
Young (11–13 weeks) and old (1 year and 2 years)
C57Bl/6J female mice were obtained from Charles
River UK, housed in a pathogen-free facility at the
University of Liverpool, UK and used in accordance
with the Animals (Scientific Procedures) Act 1986 and
the EU Directive 2010/63/EU and after local ethical
review and approval by Liverpool University's Animal
Welfare and Ethical Review Body (AWERB).
Cell culture
SC-derived primary myoblasts were obtained by
expansion in culture of primary SCs, which were
obtained, expanded and differentiated as described
previously [20] from 11 to 13 week old female mice
(Charles River) and plated either on gelatin-coatedPlease cite this article as: R.S. Ghadiali, et al., Dynamic changes in h
myoblast cell fate and FGF2 signalling, Matrix Biol (2016), http://dx.10 cm plates (for HSPG extraction, see details below)
or on gelatin-coated 12 multi-well plates (for screening
of HS mimetics, see details below). SC-derived
myoblasts were expanded in growth medium
(F12 + 0.4 mM CaCl2 + 15% horse serum
(HyClone) + 1% penicillin/streptomycin + 2 mM glu-
tamine + 2 nM FGF2) under a humidified atmosphere
of 5% CO2. Recombinant human FGF2 was prepared
in house. To induce differentiation, cell cultures were
washed twice with F12C (F12 + 0.4 mM CaCl2) then
incubated in differentiation medium (F12 + 0.4 mM
CaCl2 + 3% horse serum (HyClone) + 1% penicillin/
streptomycin +2 mM glutamine) for three days.
For BrdU incorporation analysis, 10 μM BrdU was
added to the culture medium 2 h prior to cell fixation
to label all cells that were in S-phase.
For biochemistry experiments primary SCs were
replaced with C2C12 myoblasts to increase the
amount of starting material. C2C12 myoblasts [58,59]
were obtained from ATCC, grown in growth medium
(Dulbecco's Modified Eagle Medium (Invitrogen) +
10% foetal bovine serum (Invitrogen) + 1% penicillin/
streptomycin + 2 mM glutamine) under a humidified
atmosphere of 5% CO2. Cells were maintained at
40–70% confluence on uncoated plastic dishes. For
Western blot analysis, cells were serum starved for
6 h, treated with the HS mimetic and/or FGF2
and then, at the indicated time points, lysed and
processed for Western blotting as described below.
Differentiation and treatment with modified
heparins
Chemically modified heparin compounds (HS
mimetics) were prepared and kindly donated by
Dr. Ed Yates, University of Liverpool. Primary SCs
were induced to differentiate by switching to differ-
entiation medium (DMEM + 3% horse serum + 1%
penicillin/streptomycin + 2 mM glutamine) in the
presence/absence of HS mimetics for 3 days prior
to fixation with 4% paraformaldehyde prepared in
phosphate buffered saline (PBS) for 10 min at room
temperature and then washed 3 times with PBS.
Fixed cells were stored in PBS at 4 °C until
immunostaining was performed.
Immunofluoresence
For detection of myosin heavy chain (MyHC) and
Pax7, fixed cells were permeabilized with
PBS + 0.2% TritonX100 for 10 min at room temper-
ature. For BrdU immunostaining, after perme-
abilization the DNA was denatured with 3 N HCl for
20 min at RT followed by a 10 min incubation with
0.1 M sodium borate, pH 8.5 and then three washes
in PBS. For all immunostaining procedures, samples
were then blocked with 3% bovine serum albumin
(BSA) for 1 h before incubationwith primary antibodies
over night at 4 °C in PBS + 1% BSA. Primaryeparan sulfate during muscle differentiation and ageing regulate
doi.org/10.1016/j.matbio.2016.07.007
11Heparan Sulfate in Myogenesisantibodies used were: mouse monoclonal anti-MyHC
(Developmental Studies Hybridoma Bank at Iowa
University, MF20 clone) at 1:200, mouse monoclonal
anti-Pax7 (Developmental Studies Hybridoma Bank at
Iowa University) at 1:100 and rat anti-BrdU (Serotec)
at 1:100. Cells were then washed 3 times with
PBS + 0.2% TritonX100 and incubated for 1 h at
room temperature with PBS + 1% BSA + secondary
antibodies conjugatedwith AlexaFluor 488 (Invitrogen)
at 1:500 followed by incubation with 2 μg/ml DAPI (Life
Technologies) in PBS for 5 min at room temperature.
Cells were then washed 3 times with PBS + 0.2%
TritonX100 then stored at 4 °C in PBS until imaging on
an epifluorescence microscope (EVOS-FL, Life Tech-
nologies) using a 10× objective.
Extraction of HSPGs and disaccharide analysis
Quadricepsmuscleswere homogenizedwith a blade
homogenizer and solubilized in 1 ml of TUT buffer (1%
Triton ×100, 8 M urea, 10 mM Trizma Base, 0.1 mM
Na2SO4, pH 8.0), then cleared by centrifugation at
13,000 ×g for 10 min. For HSPG extraction and
disaccharide analysis from primary myoblasts, cells
were washed twice with ice-cold PBS, solubilized in
1 ml TUT buffer/10 cm2 culture dish and sonicated to
disrupt DNA. Cell or muscle homogenates were added
to diethylaminoethyl (DEAE) Sephacel beads (GE
healthcare) and incubated over night at 4 °C on gentle
mixing. The DEAE beads were washed with 10
volumes of PBS, pH 7.4 followed by 10 volumes of
PBS + 0.3 M NaCl, pH 7.4 and then eluted with 10
volumes of PBS + 2 M NaCl, pH 7.4. Eluted fractions
were desalted on HiTrap Desalting Columns (GE
healthcare) or with SnakeSkin Dialysis Tubing
(34 mm dry flat width, ThermoScientific) and
freeze-dried prior to resuspension in 100 mM sodium
acetate, 0.1 mM calcium acetate, pH 7.0 and and
digestion by sequential addition at 37 °C of 2.5 mU of
heparinase I (2 h, 37 °C) followed by 2.5 mU of
heparinase III (2 h, 37 °C) and finally with 2.5 mU of
heparinase II (2 h, 37 °C). All three enzymeswere then
added together at 2.5 mU each (16 h, 37 °C). The
enzymes were denatured at 95 °C for 5 min and ionic
interactions were disrupted with 2 M NaCl. The
enzymes and core proteins were removed using C18
Spin Columns (Life Technologies) and the salt
removed using Graphite Spin Columns (Life Technol-
ogies). The samples were then freeze-dried and then
resuspended in BODIPY hydrazide (5 mg/ml in meth-
anol). Methanol was removed by centrifugation under
vacuum, and samples were resuspended in DMSO:
acetic acid (17:3 v/v) prior to incubation for 4 h at room
temperature in the dark. Samples were snap frozen
and freeze dried. Excess free BODIPY tag was
removed by thin layer chromatography (TLC), bound
labelled disaccharides were eluted from silica scrap-
ings with deionized water (3 × 4 ml) and then
freeze-dried. 800 μl of saturated ethanol solutionPlease cite this article as: R.S. Ghadiali, et al., Dynamic changes in h
myoblast cell fate and FGF2 signalling, Matrix Biol (2016), http://dx(sodium acetate in molecular biology grade ethanol)
was added to lyophilised samples, incubated on ice
for 15 min and then centrifuged at 13,000 ×g for
5 min. The supernatant was collected and dried by
centrifugation under vacuum. The fluorescently la-
belled disaccharides were resuspended in H2O prior
to loading onto a Propac PA-1 column and eluted
using a linear gradient of 0–1 M sodium chloride
(prepared in 150 mM NaOH) over 30 min at a flow
rate of 1 ml/min on a Shimadzu HPLC system. Peaks
were detected using inline fluorescence detection at
excitation wavelength of 488 nm and an emission
wavelength of 520 nm using a Shimadzu RF-551
detector. The column was reconditioned by washing
with 2 MNaCl (in 300 mMNaOH) before equilibrating
in 150 mM NaOH. Disaccharides were identified with
reference to authentic heparin unsaturated disaccha-
ride standards (Dextra Labs, Table 1). Previously
calculated correction factors were applied to quanti-
tate the observed disaccharides.
BaF3 cell assay
Murine BaF3 lymphocytes expressing murine
FGFR1IIIc were a gift from Professor David Ornitz
(Washington University, St. Louis, USA). Cells were
maintained in RPMI-1640 supplemented + 10%
FCS + 100 Units/ml penicillin G + 100 μg/ml strepto-
mycin sulfate (all from ThermoFisher, UK) and 1 ng/ml
murine interleukin-3 (R&D Systems, UK) at 105 to
106 cells/ml at 37 °C, 5% CO2. For assays, cells were
plated at 105 cells/ml in 96-well, flat bottomed Costar
tissue culture plates (Corning, USA) in 100 μl growth
medium without interleukin-3 supplemented with
FGF-2 (R&D Systems, UK) and heparan sulfate at
the indicated concentrations. Cells were incubated for
72 h at 37 °C, 5% CO2. Thiazolyl blue tetrazolium
bromide (Sigma, UK) was then added to a final
concentration of 250 μg/ml and the cells were incubat-
ed a further 4 h at 37 °C, 5% CO2. The assay was
stopped with the addition of 50 μl 10% SDS, 0.01 N
HCl and the plates were incubated 4 h to overnight at
37 °C to dissolve the formazan product. Plates were
read at 570 nm using a Thermo multiskan EX plate
reader (ThermoFisher, UK).
Purification of HS
Muscle homogenates were added to diethylami-
noethyl (DEAE) Sephacel beads (GE Healthcare)
and incubated over-night at 4 °C on gentle mixing.
The DEAE beads were washed with 10 volumes of
PBS, pH 7.4 fol lowed by 10 volumes of
PBS + 0.3 M NaCl, pH 7.4 and then eluted with 10
volumes of PBS + 2 M NaCl, pH 7.4. Eluted frac-
tions were desalted on HiTrap Desalting Columns
(GE Healthcare) or with SnakeSkin Dialysis Tubing
(34 mm dry flat width, ThermoScientific) and
freeze-dried.eparan sulfate during muscle differentiation and ageing regulate
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Freeze-dried samples were re-suspended in 1:5
volume of 10× DNase solution (200 mM Tris–
acetate pH 8.0, 30 mM MgCl2, 50 mM CaCl2 with
1 μg/ml DNase was added for 4 h, 37 °C. 1:5
volume of 5× RNase solution was then added
(50 mM Tris pH 8.0, 25 mMEDTA, 40 mM
Na-Acetate) with 0.5 mg/ml RNase was added for
1 h, 37 °C. 1:5 volume of 5× Chondroitin ABC lyase
solution (500 mM Tris–acetate pH 8.0) with 1.25 U
cABCase was added for 4 h 37 °C. 1:5 volume of 5×
Neuraminidase buffer (250 mM Tris Acetate pH 7.5)
with 2.5 mU of neuraminidase was added for 4 h,
37 °C. 1:5 volume of 5× Keratanase buffer (250 mM
Tris Acetate, pH 7.5) with 100 mU keratanse was
added for 4 h, 37 °C. 1:5 volume of Pronase solution
(500 mM Tris–acetate, 50 mM Calcium acetate
pH 8.0) with 10 mg/ml Pronase was added for
16 h, 37 °C. The samples were then added to
(DEAE) Sephacel beads to remove the enzymes.
The isolated HS chains were eluted from the beads
as described previously. Samples were freeze-dried
and re-suspended in 100 μl filtered miliQ water. 5 μl
were taken through for heparinise digestion (de-
scribed above) for HS quantification. After the
enzymes were removed the freeze-dried samples
were re-suspended in 20 μl of miliQ water for
quantification on the nano-drop measuring the
absorbance of the double bond at 232 nm.
Western blotting
Whole cell extracts were obtained by incubating
cells in modified RIPA buffer (50 mM Tris–HCl,
pH 7.4, 1% NP-40, 0.25% sodium-deoxycholate,
150 mM NaCl, and 1 mM EDTA) supplemented with
a protease inhibitor cocktail (Complete, Roche) and
phosphatase inhibitors (2 mM Na3VO4 and 2 mM
NaF) for 30 min on ice, then cleared by centrifuga-
tion at 13,000 ×g for 10 min at 4 °C. Total protein
content (10–30 μg) was separated on 10%
SDS-PAGE gels and transferred onto nitrocellulose
membranes (Hybond, GE Healthcare) for Western
blotting. Primary antibodies were incubated overnight
at 4 °C in PBS + 5% BSA and were: rabbit anti-p44/
42MAPK (Erk1/2,Cell Signaling Technology) used at
1:1000, rabbit anti-Phospho-p44/42 MAPK (P-Erk1/2,
Thr202/Tyr204, Cell Signaling Technology) used at
1:1000. Anti–rabbit HRP-conjugated secondary anti-Table 3. primers used for HS6ST and GAPDH qPCR and am
Gene Forward primer
GAPDH CCCCTTCATTGACCTCAACTAC
HS6ST1 CGTTCGCCCAGAAAGTTCTAC
HS6ST2 CCCTTGGCCAGCGTCG
HS6ST2 GGCAAGAAGGAGACCTGGCT
Please cite this article as: R.S. Ghadiali, et al., Dynamic changes in h
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1:10,000 in PBS + 5% BSA for 1 h at room temper-
ature, and HRP activity was visualized using the ECL
Plus system (BioRad). Images were quantified using
the “Analyze Gel” function of ImageJ.
Knockdown of HS6STs
C2C12myoblastswere seeded in a 12-well plate at a
density of 20,000 cells per well. Cells were cultured in
growth medium for 24 h after which the medium was
replacedwithOptimem(Gibco).GFPplasmid (pClover)
was co transfected 20 nMof eachHS6ST siRNA using
with Lipofectamine2000. siRNA sequences were
obta ined f rom Sigma Ald r i ch (HS6ST1,
SASI_Mm01_00066864; HS6ST2, SASI_
Mm02_00292422; HS6ST1, SASI_Mm01_00105592;
universal negative control 1). The extent of gene
knockdown was assessed by quantitative real time
PCR (qPCR) using RNA purified from siRNA-treated
cells 24 h post transfection. To assess proliferation of
siRNA-treated cells, 22 h post transfection a BrdU
proliferation assay was performed on myoblasts in the
12-well plates.
qPCR
RNA was isolated using a Qiagen RNeasy Mini Kit
(Qiagen) following manufacturer's instructions. RNA
quality and integrity were checked using a Nanodrop
1000 (Thermo Fisher Scientific). Following RNA
extraction, cDNA was synthesised from a maximum
of 5 μg of RNA using the Tetro cDNA Synthesis Kit
(Bioline). Gene expression was quantified by qPCR
using the LightCycler 460 SYBR Green I Master kit
(Roche) with 5 μl cDNA corresponding to 20 ng total
RNA in a 20 μl final volume and 0.4 μM of each
primer. Experiments were performed in duplicate for
each sample in a 96-well plate (Roche). The PCR
programme was set as: 95 °C for 5 min followed by
45 cycles at 95 °C for 12 s, 57 °C for 10 s, and 72 °C
for 10 s. Amplification specificity was checked using a
melting curve following the manufacturer's instruc-
tions. Primers were designed using the NCBI
Primer-BLAST software to have a melting tempera-
ture of 60 °C and an amplicon size between 100 and
200 base pairs (Table 3). Primers were purchased
from Eurofins Genomics. Results were analysed with
the LightCycler software (Roche) using the second
derivativemaximummethod to set the threshold cycleplicon size.
Reverse primer Size
TCCACGACATACTCAGCACC 182
CACACATGTGCAAGGAGGTC 118
GCACACGTATTGGACGA 102
GTAGAAATTCCTGGTGTGGCTGTG 150
eparan sulfate during muscle differentiation and ageing regulate
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out using the comparative CT method (2
−ΔΔCT)
method such that expression levels of all three
HS6STs were first normalised to the reference gene
glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) and then the normalised HS6ST/GAPDH
values obtained from cells transfected with HS6ST
siRNAs were expressed as percentage of the
HS6ST/GAPDH values obtained from cells trans-
fected with control (scrambled) siRNA.
Image processing, analysis and figure preparation
Photoshop 7.0 (Adobe Systems) was used to
linearly reduce the background throughout the whole
image using contrast and brightness adjustments and
to compose the figures. For immunofluorescence
image quantification a bespoke macro written for Fiji
(available at [http://fiji.sc]) was applied and for each
image the following data were generated: numbers of
nuclei, numbers of cells expressing MyHC, numbers of
nuclei present in myotubes and total myotube area.
Assistance in analysis was provided by the Liverpool
Centre for Cell Imaging, University of Liverpool.
Statistical analysis
Statistical analysis was performed using Graph-
Pad Prism (version 5.00 for Mac, GraphPad Soft-
ware, San Diego California USA) and Excel
(Microsoft, USA). Values are reported as the
mean ± standard error of the mean (S.E.M.) for
normal data. A one-way ANOVA or an un-paired
t-test was used for statistical analysis. Data was
deemed statistically significant when p b 0.05.Acknowledgements
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